Table 2.
Histologic type | Model 2: LBD cancers with unknown histology only |
Model 3: LBD cancers with unknown histology+C76.2 and C80.9 |
||
---|---|---|---|---|
Male (n=1,152) | Female (n=303) | Male (n=1,323) | Female (n=421) | |
HCC | ||||
95% PI (n) | 586 (552-620) | 74 (64-84) | 675 (639-711) | 104 (89-119) |
95% PI (%) | 50.9 (47.9-53.8) | 24.4 (21-27.9) | 51 (48.3-53.8) | 24.7 (21.3-28.2) |
CCA | ||||
95% PI (n) | 394 (362-426) | 152 (140-164) | 451 (363-423) | 211 (140-164) |
95% PI (%) | 34.2 (31.4-37) | 50.2 (46.2-54.2) | 34.1 (31.5-36.7) | 50.1 (46.1-54.1) |
OSCA | ||||
95% PI (n) | 172 (148-196) | 77 (66-88) | 197 (149-194) | 106 (66-87) |
95% PI (%) | 14.9 (12.8-17) | 25.4 (21.9-28.9) | 14.9 (12.9-16.8) | 25.2 (21.7-28.7) |
LBD, liver and bile duct; C76.2, unknown primary in the abdomen; C80.9, unknown primary site, not otherwise specified; HCC, hepatocellular carcinoma; PI, probability interval; CCA, cholangiocarcinoma; OSCA, other specified histology cancers.